120 related articles for article (PubMed ID: 37226983)
21. Clinical impact of elastic laminal invasion in colon cancer: elastic laminal invasion-positive stage II colon cancer is a high-risk equivalent to stage III.
Yokota M; Kojima M; Nomura S; Nishizawa Y; Kobayashi A; Ito M; Ochiai A; Saito N
Dis Colon Rectum; 2014 Jul; 57(7):830-8. PubMed ID: 24901683
[TBL] [Abstract][Full Text] [Related]
22. Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.
Mlecnik B; Bifulco C; Bindea G; Marliot F; Lugli A; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert C; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang JY; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Bruni D; Lanzi A; El Sissy C; Haicheur N; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; van Lent-van Vliet S; Knijn N; Muşină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Itoh K; Patel PS; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
J Clin Oncol; 2020 Nov; 38(31):3638-3651. PubMed ID: 32897827
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Impact of pT Stage and Peritoneal Invasion in Locally Advanced Colon Cancer.
Baguena G; Pellino G; Frasson M; Roselló S; Cervantes A; García-Granero A; Giner F; García-Granero E
Dis Colon Rectum; 2019 Jun; 62(6):684-693. PubMed ID: 30839315
[TBL] [Abstract][Full Text] [Related]
24. [Laparoscopic diagnosis of postoperative recurrence of peritoneal metastasis in gastric cancer patients and the clinical efficacy of bidirectional intraperitoneal and systemic chemotherapy].
Yan C; Yang ZY; Shi M; Xu W; Ni ZT; Hua ZC; Liu WT; Zhu ZL; Bi RD; Zheng YN; Feng RH; Yao XX; Chen MM; Li C; Zhang J; Yan M; Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 May; 23(5):492-498. PubMed ID: 32842430
[No Abstract] [Full Text] [Related]
25. Prevention of peritoneal recurrence in high-risk colorectal cancer and evidence of T4 status as a potential risk factor.
Kyang LS; Valle SJ; Alzahrani NA; Morris DL
ANZ J Surg; 2018 Oct; 88(10):975-981. PubMed ID: 29510456
[TBL] [Abstract][Full Text] [Related]
26. Metachronous Peritoneal Metastases After Adjuvant Chemotherapy are Associated with Poor Outcome After Cytoreduction and HIPEC.
Sluiter NR; Rovers KP; Salhi Y; Vlek SL; Coupé VMH; Verheul HMW; Kazemier G; de Hingh IHJT; Tuynman JB
Ann Surg Oncol; 2018 Aug; 25(8):2347-2356. PubMed ID: 29855834
[TBL] [Abstract][Full Text] [Related]
27. Clinical outcomes of curative surgical resection of peritoneal metastasis in patients with colorectal cancer: A long-term follow-up study.
Bang K; Kim JE; Kim TW; Kim SY; Lim SB; Park IJ; Kim CW; Yoon YS; Hong YS
Cancer Med; 2023 Feb; 12(3):2861-2868. PubMed ID: 36069152
[TBL] [Abstract][Full Text] [Related]
28. Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer.
Kang Y; Li S; Ge Q; Liu X; Yang Z; Xue Y; Wang F
Medicine (Baltimore); 2015 Oct; 94(42):e1750. PubMed ID: 26496292
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial.
Klaver CEL; Wisselink DD; Punt CJA; Snaebjornsson P; Crezee J; Aalbers AGJ; Brandt A; Bremers AJA; Burger JWA; Fabry HFJ; Ferenschild F; Festen S; van Grevenstein WMU; Hemmer PHJ; de Hingh IHJT; Kok NFM; Musters GD; Schoonderwoerd L; Tuynman JB; van de Ven AWH; van Westreenen HL; Wiezer MJ; Zimmerman DDE; van Zweeden AA; Dijkgraaf MGW; Tanis PJ;
Lancet Gastroenterol Hepatol; 2019 Oct; 4(10):761-770. PubMed ID: 31371228
[TBL] [Abstract][Full Text] [Related]
30. Peritoneal cancer index (PCI) based patient selecting strategy for complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in gastric cancer with peritoneal metastasis: A single-center retrospective analysis of 125 patients.
Ji ZH; Yu Y; Liu G; Zhang YB; An SL; Li B; Li XB; Yan GJ; Li Y
Eur J Surg Oncol; 2021 Jun; 47(6):1411-1419. PubMed ID: 33293213
[TBL] [Abstract][Full Text] [Related]
31. High risk features of primary colorectal carcinomas which subsequently undergo peritonectomy.
Leung V; Huang N; Liauw W; Morris DL
Eur J Surg Oncol; 2016 Jun; 42(6):836-40. PubMed ID: 26995114
[TBL] [Abstract][Full Text] [Related]
32. A population-based study on the prognostic impact of primary tumor sidedness in patients with peritoneal metastases from colon cancer.
de Boer NL; Rovers K; Burger JWA; Madsen EVE; Brandt-Kerkhof ARM; Kok NFM; de Wilt JHW; de Reuver PH; Bos A; de Hingh IHJT; Verhoef C
Cancer Med; 2020 Aug; 9(16):5851-5859. PubMed ID: 32614506
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.
Ishigami S; Uenosono Y; Arigami T; Yanagita S; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Nakajo A; Maemura K; Natsugoe S
World J Surg Oncol; 2014 Nov; 12():350. PubMed ID: 25407392
[TBL] [Abstract][Full Text] [Related]
34. Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases.
Baratti D; Kusamura S; Iusco D; Gimondi S; Pietrantonio F; Milione M; Guaglio M; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
Ann Surg Oncol; 2017 Jan; 24(1):167-175. PubMed ID: 27519353
[TBL] [Abstract][Full Text] [Related]
35. Laparoscopic Colectomy: A Risk Factor for Postoperative Peritoneal Metastasis.
Nagata H; Kawai K; Oba K; Nozawa H; Yamauchi S; Sugihara K; Ishihara S
Clin Colorectal Cancer; 2022 Sep; 21(3):e205-e212. PubMed ID: 35691832
[TBL] [Abstract][Full Text] [Related]
36. Microsatellite and RAS/RAF Mutational Status as Prognostic Factors in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
Tonello M; Baratti D; Sammartino P; Di Giorgio A; Robella M; Sassaroli C; Framarini M; Valle M; Macrì A; Graziosi L; Coccolini F; Lippolis PV; Gelmini R; Deraco M; Biacchi D; Santullo F; Vaira M; Di Lauro K; D'Acapito F; Carboni F; Giuffrè G; Donini A; Fugazzola P; Faviana P; Sorrentino L; Scapinello A; Del Bianco P; Sommariva A
Ann Surg Oncol; 2022 Jun; 29(6):3405-3417. PubMed ID: 34783946
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial.
Klaver CE; Musters GD; Bemelman WA; Punt CJ; Verwaal VJ; Dijkgraaf MG; Aalbers AG; van der Bilt JD; Boerma D; Bremers AJ; Burger JW; Buskens CJ; Evers P; van Ginkel RJ; van Grevenstein WM; Hemmer PH; de Hingh IH; Lammers LA; van Leeuwen BL; Meijerink WJ; Nienhuijs SW; Pon J; Radema SA; van Ramshorst B; Snaebjornsson P; Tuynman JB; Te Velde EA; Wiezer MJ; de Wilt JH; Tanis PJ
BMC Cancer; 2015 May; 15():428. PubMed ID: 26003804
[TBL] [Abstract][Full Text] [Related]
38. Percutaneous lung ablation of pulmonary recurrence may improve survival in selected patients undergoing cytoreductive surgery for colorectal cancer with peritoneal carcinomatosis.
Bin Traiki TA; Fisher OM; Valle SJ; Parikh RN; Kozman MA; Glenn D; Power M; Liauw W; Alzahrani NA; Morris DL
Eur J Surg Oncol; 2017 Oct; 43(10):1939-1948. PubMed ID: 28888800
[TBL] [Abstract][Full Text] [Related]
39. Management of colorectal cancer patients at high risk of peritoneal metastases.
Shariff U; Seretis C; Youssef H
J BUON; 2015 May; 20 Suppl 1():S71-9. PubMed ID: 26051336
[TBL] [Abstract][Full Text] [Related]
40. Colic and rectal tumors with peritoneal metastases treated with cytoreductive surgery and HIPEC: One homogeneous condition or two different diseases? A systematic review and meta-analysis.
Tonello M; Sommariva A; Pirozzolo G; Mattara G; Pilati P
Eur J Surg Oncol; 2019 Nov; 45(11):2003-2008. PubMed ID: 31217079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
